Published in Pediatr Diabetes on July 01, 2016
Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis. Mol Metab (2017) 0.75
Autoreactive T cells in type 1 diabetes. J Clin Invest (2017) 0.75
Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes (1965) 6.00
In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med (1985) 4.65
Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia (2005) 4.61
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA (2013) 3.65
Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data. Diabetes (2012) 3.11
Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes (2010) 2.94
Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med (2012) 2.86
The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia (1986) 2.73
Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay. Diabetes Care (2012) 2.45
Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes (2010) 2.36
Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care (2006) 2.15
Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia (2010) 2.04
Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study. Diabetologia (2014) 2.04
Screening for insulitis in adult autoantibody-positive organ donors. Diabetes (2007) 2.02
Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am (2010) 2.02
Natural history of beta-cell function in type 1 diabetes. Diabetes (2005) 1.98
Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients. J Clin Invest (2010) 1.93
Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes. Diabetes (2014) 1.89
Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes. Diabetes (2015) 1.88
The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia (2014) 1.83
Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes (2014) 1.67
Differential Insulitic Profiles Determine the Extent of β-Cell Destruction and the Age at Onset of Type 1 Diabetes. Diabetes (2016) 1.63
Insulitis in human type 1 diabetes: The quest for an elusive lesion. Islets (2011) 1.61
Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset. Diabetes (2009) 1.54
Accurate measurement of pancreatic islet beta-cell mass using a second-generation fluorescent exendin-4 analog. Proc Natl Acad Sci U S A (2011) 1.50
The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings. Pediatr Diabetes (2013) 1.46
Analysis of peri-islet CD45-positive leucocytic infiltrates in long-standing type 1 diabetic patients. Diabetologia (2015) 1.42
The diagnosis of insulitis in human type 1 diabetes. Diabetologia (2013) 1.33
Preservation of beta-cell function in autoantibody-positive youth with diabetes. Diabetes Care (2009) 1.32
Aberrant expression of HLA-DR antigens by insulin-containing beta-cells in recent-onset type I diabetes mellitus. Diabetes (1986) 1.31
β cell death and dysfunction during type 1 diabetes development in at-risk individuals. J Clin Invest (2015) 1.31
Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes. Diabetologia (2012) 1.27
The peri-islet basement membrane, a barrier to infiltrating leukocytes in type 1 diabetes in mouse and human. Diabetes (2012) 1.27
Initial results of screening of nondiabetic organ donors for expression of islet autoantibodies. J Clin Endocrinol Metab (2006) 1.27
The rise and fall of insulin secretion in type 1 diabetes mellitus. Diabetologia (2006) 1.18
Development of autoantibodies in the TrialNet Natural History Study. Diabetes Care (2011) 1.09
Extent of beta cell destruction is important but insufficient to predict the onset of type 1 diabetes mellitus. PLoS One (2008) 1.05
Analysis of pancreas tissue in a child positive for islet cell antibodies. Diabetologia (2008) 1.03
Prevention and reversal of type 1 diabetes--past challenges and future opportunities. Diabetes Care (2015) 0.98
Collecting high-quality pancreatic tissue for experimental study from organ donors with signs of β-cell autoimmunity. Diabetes Metab Res Rev (2010) 0.96
Increased vulnerability of newly forming beta cells to cytokine-induced cell death. Diabetologia (2005) 0.95
Characterization of human organ donors testing positive for type 1 diabetes-associated autoantibodies. Clin Exp Immunol (2015) 0.95
Hyaluronan and hyaluronan-binding proteins accumulate in both human type 1 diabetic islets and lymphoid tissues and associate with inflammatory cells in insulitis. Diabetes (2014) 0.92
Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes. Diabetologia (2015) 0.91
Islet inflammation in human type 1 diabetes mellitus. IUBMB Life (2014) 0.90
Expression pattern of 12-lipoxygenase in human islets with type 1 diabetes and type 2 diabetes. J Clin Endocrinol Metab (2014) 0.89
Glucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1). Diabetes (2010) 0.89
Age-corrected beta cell mass following onset of type 1 diabetes mellitus correlates with plasma C-peptide in humans. PLoS One (2011) 0.89
Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors. Diabetes Care (2014) 0.87
β-cell Mass in Nondiabetic Autoantibody-Positive Subjects: An Analysis Based on the Network for Pancreatic Organ Donors Database. J Clin Endocrinol Metab (2016) 0.85
Extracellular matrix components in the pathogenesis of type 1 diabetes. Curr Diab Rep (2014) 0.85
Persistent glucose transporter expression on pancreatic beta cells from longstanding type 1 diabetic individuals. Diabetes Metab Res Rev (2011) 0.85
Advances in the etiology and mechanisms of type 1 diabetes. Discov Med (2014) 0.83
Prospective evaluation of risk factors for the development of islet autoimmunity and type 1 diabetes during puberty--TEENDIAB: study design. Pediatr Diabetes (2011) 0.82
Inhibition of hyaluronan synthesis restores immune tolerance during autoimmune insulitis. J Clin Invest (2015) 0.82
Characterization of residual β cell function in long-standing type 1 diabetes. Diabetes Metab Res Rev (2014) 0.81
Proteomic Analysis of Disease Stratified Human Pancreas Tissue Indicates Unique Signature of Type 1 Diabetes. PLoS One (2015) 0.80
Hyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarization. Proc Natl Acad Sci U S A (2016) 0.78
Lipids and immunoinflammatory pathways of beta cell destruction. Diabetologia (2016) 0.78